FindTrial
Sign In

Identification of the new biomarkers of amyotrophic lateral sclerosis

Identification of the new biomarkers of amyotrophic lateral sclerosis - Identification of the new biomarkers of amyotrophic lateral sclerosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000013111
Enrollment
60
Registered
2014-02-12
Start date
2014-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amyotrophic lateral sclerosis

Interventions

None listed

Sponsors

Nagoya University Graduate school of Medicine
Lead Sponsor
Division of Neurology, Department of Medicine, Jichi Medical school National Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders Department of Neurology, Mie University Graduate School of Medicine
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Those patients who received diagnosis of ALS and joined to JaCALS which is a cohort study of ALS.

Exclusion criteria

Exclusion criteria: The patients who have the multiple neurodegenerative diseases.

Design outcomes

Primary

MeasureTime frame
Identify the useful biomarkers which are correlated to the clinical course and the disease state of ALS—

Countries

Japan

Contacts

Public ContactKensuke Ikenaka

Nagoya University Graduate school of Medicine Department of Neurology

ikenakaman@med.nagoya-u.ac.jp052-744-2391

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026